NasdaqGS - Delayed Quote USD
Passage Bio, Inc. (PASG)
At close: October 18 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BORTHWICK KATHLEEN Chief Financial Officer | Sale | Feb 13, 2024 | 28,466 |
| CALE EDGAR B. General Counsel | Sale | Jan 2, 2024 | 45,995 |
| FORMAN MARK S M.D., PH.D. Officer | Sale | Feb 13, 2024 | 48,631 |
| FOTOPOULOS ALEXANDROS Chief Technology Officer | Sale | Jun 16, 2023 | 28,693 |
| KAPADIA SANDIP S. Director | Sale | Dec 1, 2022 | 0 |
| KING SIMONA Chief Financial Officer | Conversion of Exercise of derivative security | Jul 28, 2023 | 23,994 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 19, 2024 | -- |
Related Tickers
NXTC NextCure, Inc.
1.3700
-5.52%
STOK Stoke Therapeutics, Inc.
13.00
-2.03%
VOR Vor Biopharma Inc.
0.6900
-3.75%
ORIC ORIC Pharmaceuticals, Inc.
9.45
+3.28%
TSBX Turnstone Biologics Corp.
0.4891
+3.58%
PLRX Pliant Therapeutics, Inc.
15.20
+3.61%
SNSE Sensei Biotherapeutics, Inc.
0.4131
-5.25%
CMRX Chimerix, Inc.
0.8810
+1.00%
PMVP PMV Pharmaceuticals, Inc.
1.5800
-1.25%
CABA Cabaletta Bio, Inc.
4.9050
+1.13%